Editorial: Drug Repurposing

Front Med (Lausanne). 2019 Jul 3:6:154. doi: 10.3389/fmed.2019.00154. eCollection 2019.

Pan Pantziarka^{1

2

3}, Nicolas André^{3

4

5}

¹ Anticancer Fund, Brussels, Belgium.
² The George Pantziarka TP53 Trust, London, United Kingdom.
³ Metronomics Global Health Initiative, Marseille, France.
⁴ Department of Pediatric Hematology-Oncology, Assistance Publique Hôpitaux de Marseille, La Timone Hospital, Marseille, France.
⁵ Centre de Recherche en Cancérologie de Marseille (CRCM, Marseille Cancer Research Centre), SMARTC, Inserm UMR1068, CNRS UMR7258, Aix-Marseille University UM105, Marseille, France.

No abstract available

Keywords: clinical cancer research; drug development; drug repositioning; drug repurposing; oncology.

Publication types